T-CELL LEUKEMIA
Clinical trials for T-CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered T-Cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called CD4CAR for people with T-cell leukemia or lymphoma that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. The…
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New trial aims to stop a deadly cancer before it starts
Prevention Recruiting nowThis phase 2 study tests whether the drug mogamulizumab can prevent adult T-cell leukemia/lymphoma (ATL) in people infected with HTLV-1 who are at high risk. About 134 participants will receive low doses of the drug over several weeks. The goal is to see if it can reduce the viru…
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 23, 2026 11:58 UTC
-
Rare leukemia study seeks to unlock secrets of T-PLL
Knowledge-focused Recruiting nowThis study is gathering information from 50 people with a rare and aggressive blood cancer called T-cell prolymphocytic leukemia (T-PLL). Researchers will look at medical records, lab results, and genetic data to better understand the disease and how patients respond to current t…
Matched conditions: T-CELL LEUKEMIA
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated May 26, 2026 12:00 UTC